From Remission and Regression of Diseases to Controlled Normal Life Activity

Abstract

Remission and regression are concepts related to disease dynamics, particularly in oncology, but also used in other areas of medicine. They describe the reduction or disappearance of symptoms and signs of a disease, which can lead to the restoration of normal life. However, it is important to understand that remission does not always mean a complete cure, while regression indicates a stable improvement in a patient’s condition. Upon achieving remission or regression, a patient can gradually return to their normal life, engage in professional activities, interact with different people, and maintain physical activity. Remission and regression are important stages in disease treatment. Modern technologies for disease remission and regression are actively developing in several areas, including cancer, autoimmune, and rheumatic diseases. These include both established methods and innovative approaches based on advances in genetic engineering, immunotherapy, and other technologies. Research into disease remission and regression is an active area of research aimed at improving patient outcomes and developing more effective therapeutic strategies. Research into disease remission and regression spans various fields of medicine, including oncology and endocrinology. Studies show that early and long-term remission improves functional outcomes. Efforts to standardize remission and regression across various fields of medicine are ongoing to improve diagnosis, functional status, and comparison of research results.